Creating a Path Forward: Diverse Representation in Clinical Trials for Alzheimer’s Disease
Release: 3/27/2023 (no credits available)
Faculty
Peggye Dilworth-Anderson, PhD
Professor, Dept of Health Policy and Management
University of North Carolina-Chapel Hill
James E. Galvin, MD, MPH
Professor of Neurology
University of Miami
Victor Narcisse, MD, FACP
Associate Division Head, Hospital Medicine
Houston Methodist Hospital
| Copyright Statement with Logo | Home Office Alzheimer's Association National Office, 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601 Alzheimer's Association is a not-for-profit 501(c)(3) organization. © 2021 Alzheimer’s Association®. All rights reserved.  |
| Target Audience / Intended Audience | This activity is intended for primary care clinicians including internists, family physicians, nurse practitioners, and physician assistants as well as specialists who work with patients with cognitive impairment or dementia. |
| Statement of Need / Activity Purpose |
Clinical trial participation is low amongst diverse populations. The purpose of this course is so we to increase awareness on the importance of representation and provide clinicians with the tools and resources to effectively communicate around clinical trials and recruit their patients. |
| Learning Objectives |
Upon completion of this webinar you will learn:
|
| Faculty Disclosures |
Disclosures- Faculty reports the following relationship(s) Individuals in control of content have disclosed the following: James Galvin, MD, MPH – Consultant, Alpha-Cognition, Biogen, Cognivue, Eisai, Genentech, Roche All of the relevant financial relationships listed for these individuals have been mitigated. The remaining course director(s), planner(s), faculty, and reviewer(s) of this activity have no relevant financial relationship(s) with ineligible companies to disclose. |
| Hardware and Software Requirements |
Hardware and Software Requirements
|